Title of Product:
Lidocaine 4% Topical Anesthetic Cream
The product incorporates lidocaine which have to be in baby resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging isn’t baby resistant, posing a danger of poisoning to younger youngsters in the event that they ingest the anesthetic cream.
June 30, 2022
The recall entails Mohnark Prescription drugs Lidocaine 4% Topical Anesthetic Cream. The product was offered in a white tube with a flip-top closure. Mohnark Prescription drugs is printed beneath the blue and inexperienced brand on the suitable aspect of the product tube. The lot code is positioned on the backside of the product tube. The affected lot codes are 01202201, 210201, 210301, 210503, 210505, 210601, 211002 and 210401. The UPC 860002324906 is positioned on backside aspect panel of the packaging.
Shoppers ought to instantly cease utilizing the recalled cream and retailer it in a location out of sight and attain of kids. Contact Mohnark Prescription drugs for directions on get rid of the product to obtain a full refund. Mohnark Prescription drugs is contacting all recognized purchasers instantly.
On-line at Amazon.com and Walmart.com from January 2021 by way of January 2022 for about $7.
Mohnark Prescription drugs Inc., of Davie, Fla.
Concerning the U.S. CPSC
The U.S. Shopper Product Security Fee (CPSC) is charged with defending the general public from unreasonable danger of harm or dying related to the usage of hundreds of sorts of shopper merchandise. Deaths, accidents, and property injury from shopper product-related incidents value the nation greater than $1 trillion yearly. CPSC’s work to make sure the security of shopper merchandise has contributed to a decline within the price of accidents related to shopper merchandise over the previous 50 years.
Federal regulation prohibits any particular person from promoting merchandise topic to a Fee ordered recall or a voluntary recall undertaken in session with the CPSC.
For lifesaving data:
Report an unsafe product